News
Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced positive, initial 3-month results from the Omny-IRE study, evaluating the investigational OMNYPULSEtm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback